SIBIONICS Takes CGM Beyond Glucose, Linking Biosensing, AI and the Next Era of Diabetes Care
Continuous glucose monitoring has already changed diabetes care by replacing isolated finger-stick readings with a near-continuous picture of how glucose behaves throughout the day. The next challenge is figuring out what to do with all that data. SIBIONICS is betting that the answer lies beyond glucose itself. The medical technology company is positioning its GS3…
